Skip to Main Content

Paper Details

Impact of concomitant cardiovascular medications on overall survival in patients with liver cirrhosis.
Scand J Gastroenterol
1
2023
Liver cirrhosis, Patients, amiodarone, angiotensin II receptor, angiotensin-converting enzyme, cardiovascular comorbidity, carvedilol, cirrhosis, cirrhotic, clopidogrel, digoxin, end-stage liver disease, liver cirrhosis, losartan, patients, ramipril
Author NameAffiliation
Joo Hun ParkAjou University Graduate School of Medicine
Rae Woong ParkAjou University Graduate School of Medicine
Rae Woong ParkAjou University School of Medicine
Rae Woong ParkAjou University Graduate School of Medicine
Rae Woong ParkAjou University School of Medicine
George HripcsakColumbia University Irving Medical Center
George HripcsakColumbia University Irving Medical Center
  • 1 - 7

Datasets

Release 1.2